Author: Williamson, Anna-Lise
Similar Items: Investigation of recombinant BCG as a vector to deliver HPV-11 L1 vaccines
- The development of novel HIV-1 vaccines using modified recombinant BCG
- Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate
- Recombinant BCG expressing rotavirus VP6 : construction and evaluation as an anti-rotavirus vaccine
- Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
- Cellular immunity of naïve and BCG vaccinated neonates
- An evaluation of the vaccine-vector potential of thymidine kinase-disrupted recombinants of lumpy skin disease virus (South African vaccine)